Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06267313 · ClinicalTrials.gov registry record · NA
Attention Training for COVID-19 Related Distress
A NA study, sponsored by Palo Alto University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06267313 is a NA study that was terminated before completion, run by Palo Alto University. The registered enrollment target is 6 participants.
The verdict
NCT06267313, a NA study, was terminated before completion, sponsored by Palo Alto University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.
Interventions
- BEHAVIORAL Attention Bias Modification
- BEHAVIORAL Attention Control Training
- BEHAVIORAL Neutral training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2024-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06267313
The ClinicalTrials.gov registry entry for NCT06267313 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Attention Bias Modification is the first listed.
NCT06267313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06267313 about?
NCT06267313 is a clinical study titled "Attention Training for COVID-19 Related Distress". The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.
What is the current status of trial NCT06267313?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2024-02-19. Estimated completion is 2024-11-09.
What interventions are being tested in trial NCT06267313?
The interventions under investigation include: Attention Bias Modification (BEHAVIORAL), Attention Control Training (BEHAVIORAL), Neutral training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06267313?
This trial is sponsored by Palo Alto University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.